Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4261 results

Sort By:

Effects Of Isolated And Integrated Core Stability Training In Fast Bowlers

Study ID: NCT06688227
Start Date: 2024-11-30
End Date: 2025-05-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

28

Intervention / Treatment

Isolated Core Stability Program

Integrated Core Stability Program

Sponsor

Sehat Medical Complex

Source: clinicaltrials.gov

Share:
Add to list

Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors

Study ID: NCT06684327
Start Date: 2024-11-30
End Date: 2027-12-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Albumin-paclitaxel Injection

Sponsor

Fudan University

Source: clinicaltrials.gov

Share:
Add to list

ACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)/AML

Study ID: NCT06463327
Start Date: 2025-01
End Date: 2027-06
Study Type

Interventional

Study Phase

Phase1

No. of Participants

69

Intervention / Treatment

TCB008

Sponsor

TC Biopharm

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of the InterFACE-AR System for Cardiopulmonary Arrest

Study ID: NCT06411327
Start Date: 2025-01-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

Augmented reality

LCD Screen

Sponsor

KidSIM Simulation Program

Source: clinicaltrials.gov

Share:
Add to list

Hormonal Influences on Inflammatory Bowel Diseases

Study ID: NCT05610527
Start Date: 2024-12-01
End Date: 2027-03-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Proposed study design and randomization scenarios

Repeated measures of validated Inflammatory Bowel Disease Patient Reported Outcome Instruments

Inflammatory marker collection and assessment for correlation with PRO responses and menstrual timing

Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez

Study ID: NCT06423573
Start Date: 2024-11-30
End Date: 2032-08-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

580

Intervention / Treatment

Filsuvez

Sponsor

Amryt Pharma

Source: clinicaltrials.gov

Share:
Add to list

Linaclotide for Colonoscopy Bowel Prep

Study ID: NCT06692673
Start Date: 2024-12-01
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

10

Intervention / Treatment

Use of Linaclotide as a single agent Colonoscopy prep

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application

Study ID: NCT06425029
Start Date: 2024-12-01
End Date: 2026-03-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

Experimental Intervention (Music A)

Active Comparator Intervention (Music B)

Active Comparator Intervention (Music C)

Sponsor

Dartmouth-Hitchcock Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Effect of RECK in Posterior Spinal Fusion

Study ID: NCT06447194
Start Date: 2025-04-01
End Date: 2027-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

72

Intervention / Treatment

Ropivacaine, Epinephrine, Clonidine, and Ketorolac Injection Cocktail

Placebo

Sponsor

University of Maryland, Baltimore

Source: clinicaltrials.gov

Share:
Add to list

MB-105 in Patients With CD5 Positive T-cell Lymphoma

Study ID: NCT06534060
Start Date: 2025-02
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

46

Intervention / Treatment

Genetic: MB-105

Sponsor

March Biosciences Inc

Source: clinicaltrials.gov

Share:
Add to list